Identification and characterization of human metabolites of CAI [5- amino-1-1(4'-chlorobenzoyl-3,5-dichlorobenzyl)-1,2,3-triazole-4-carboxamide)

Drug Metabolism and Disposition

Volumn 24, Issue 7, 1996, Pages 799-806

  Soltis, Mathew J ^a   Yeh, Herman J ^b   Cole, Kristina A ^a   Whittaker, Noel ^b   Wersto, Robert P ^a   Kohn, Elise C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Natl Inst Diabet Digest K   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DICHLORO 4 (4' CHLOROBENZOYL)BENZOIC ACID; 5 AMINO 1 (4' CHLOROBENZOYL 3,5 DICHLOROBENZYL) 1,2,3 TRIAZOLE 4 CARBOXAMIDE; ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; BENZOPHENONE DERIVATIVE; BETA GLUCURONIDASE; CARBACHOL; DRUG METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; ASCITES FLUID; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DRUG CONJUGATION; DRUG EXCRETION; DRUG GLUCURONIDATION; DRUG IDENTIFICATION; DRUG INDUCED DISEASE; DRUG METABOLISM; HUMAN; HUMAN CELL; NAUSEA; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PLASMA; PLEURA FLUID; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VOMITING;

ANTINEOPLASTIC AGENTS; ARACHIDONIC ACID; ASCITIC FLUID; BENZOATES; CALCIUM; CELL DIVISION; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXUDATES AND TRANSUDATES; GLUCURONATES; GLUCURONIDASE; HUMANS; LUNG; TRIAZOLES; TUMOR CELLS, CULTURED;

EID: 0030056717     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. E. C. Kohn and L. A. Liotta: L651582, a novel antiproliferative and antimetastasis agent. J. Natl. Cancer Inst. 82, 54-50 (1990).
2. E. C. Kohn, M. A. Sandeen, and L. A. Liotta: In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. Cancer Res. 52, 3208-3212 (1992).
3. E. C. Kohn, R. Alessandro, J. Spoonster, R. Wersto, and L. A. Liotta: Angiogenesis: role of calcium-mediated signal transduction. Proc. Natl. Acad. Sci. U.S.A. 92, 1307-1311 (1995).
4. E. C. Kohn, W. Jacobs, Y. S. Kim, R. Alessandro, W. G. Stetler-Stevenson, and L. A. Liotta: Calcium influx modulates expression of matrix metalloproteinase-2 (72 kDa type IV collagenase, gelatinase A) expression. J. Biol. Chem. 269, 21505-21511 (1994).
5. C. C. Felder, A. L. Ma, L. A. Liotta, and E. C. Kohn: The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release. J. Pharmacol. Exp. Ther. 257, 967-971 (1991).
6. F. Gusovsky, J. E. Lueders, E. C. Kohn, and C. C. Felder: Muscarinic receptor-mediated tyrosine phosphorylation of phospholipase C-gamma: alternative mechanism for cholinergic receptor-induced phosphoinositide breakdown. J. Biol. Chem. 268, 7768-7772 (1993).
7. E. C. Kohn, C. C. Felder, W. Jacobs, K. A. Holmes, A. F. Day, R. Freer, and L. A. Liotta: Structure function analysis of signal and growth inhibition by carboxyamido-triazole, CAI. Cancer Res. 54, 935-942 (1994).
8. E. C. Kohn, E. Reed, E. Sarosy, M. Christian, C. J. Link, K. A. Cole, W. D. Figg, P. A. Davis, J. Jacob, B. Goldspiel, and L. A. Liotta: Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers. Cancer Res. 56, 569-573 (1996).
9. W. D. Figg, K. A. Cole, E. Reed, S. M. Steinberg, S. C. Piscitelli, P. A. Davis, M. J. Soltis, J. Jacob, S. Soudoulas, B. Goldspiel, G. Sarosy, L. A. Liotta, and E. C. Kohn: Pharmacokinetics of orally administered carboxyamido-triazole (CAI), an inhibitor of calcium-mediated signal transduction. Clin. Cancer Res. 1, 797-803 (1995).
10. K. A. Holmes, C. Chaffins, B. Osborne, L. A. Liotta, and E. C. Kohn: Quantitation of plasma levels of a novel anticancer drug, carboxyamidotriazole (CAI) by high pressure liquid chromatography. J. Chrom. Biomed. Appl. 613, 317-325 (1993).
11. L. K. Ludden, J. M. Strong, E. C. Kohn, and J. M. Collins: Similarity of metabolism for CAI (NSC 609974) in human liver tissue in vitro and in humans in vivo. Clin. Cancer Res. 1, 399-405 (1995).
12. M. W. Sinz and R. P. Remmel: Isolation and characterization of a novel quaternary ammonium-liked glucuronide of lamotrigne. Drug Metab. Dispos. 19, 149-153 (1991).
13. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450 (1985).
14. 2 by inducing both calcium influx and activation of protein kinase C. J. Pharmacol. Exp. Ther. 255, 1140-1147 (1990).
15. S. A. Wrighton and J. C. Stevens: The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 22, 1-21 (1992).
16. T. K. Hansen, K. F. Thomsen, and H. Bundagaard: Glucuronidation of the dopamine D-1 receptor antagonists NNC 0756 and NNC 0772 in liver microsomes. Drug Metab. Dispos. 20, 172-178 (1992).